1 / 5JPMorgan on Auro Pharma: The brokerage is 'overweight' on the stock and raised its target to Rs 1,100 per share from Rs 1,050 earlier. It added that valuation discount to peers with US-dependent earnings growth is unwarranted.
2 / 5Nomura on Hero Moto: The brokerage is 'neutral' on the stock with a target at Rs 3,561 per share. Gogoro partnership for battery swapping will help in the electric two-wheeler ecosystem, it said.
3 / 5Credit Suisse on Coal India: The brokerage has an 'outperform' call on the stock with a target at Rs 195 per share. It noted that receivables from the power sector to the company fell sharply in March.
4 / 5Goldman Sachs on Nestle: The brokerage maintains a 'sell' call on the stock with a target at Rs 12,905. It is bearish on Nestle given the competitive intensity in key product categories.
5 / 5Nomura on Nestle: The brokerage has a 'buy' call on the stock with a target at Rs 20,500 per share. It sees stable sales growth with a positive bias for Nestle going ahead.
